David Schaffer, UC Berkeley. “Gene Therapy”
Dr. David Schaffer is the head of a research team at Berkeley that is working to create novel gene therapy methods, especially for the treatment of neurological conditions including Parkinson’s and Alzheimer’s. Several honors have been given to his work, including the National Academy of Sciences Prize for Research Initiatives in 2007 and the Presidential Early Career Award for Scientists and Engineers in 2000.
Schaffer has won multiple honors for his work in teaching and outreach in addition to being a dedicated mentor and researcher. He has also worked as a consultant for a number of biotechnology businesses and is a member of numerous editorial and scientific advisory boards. Dr. David Schaffer is a pioneer in the field of gene therapy and an enthusiastic researcher, mentor, and educator.
Dr. David Schaffer is a prominent American bioengineer and researcher in the field of gene therapy. The University of Notre Dame awarded Schaffer his chemical engineering bachelor’s degree in 1989, and the Massachusetts Institute of Technology (MIT) granted him his chemical engineering doctorate in 1994.
Schaffer worked as a postdoctoral scholar at Harvard Medical School after receiving his doctorate, where he created fresh strategies for delivering genes to the neurological system. After which, in 1997, he became a member of the University of California, Berkeley faculty. Now, he teaches chemical and biomolecular engineering, bioengineering, and neurology.
